Can hypereosinophilic syndrome (HES) with thrombotic complications present with a normal white blood cell (WBC) count and normal blood eosinophil levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Hypereosinophilic Syndrome with Thrombotic Complications Present with Normal WBC and Eosinophils?

No, hypereosinophilic syndrome (HES) by definition cannot present with normal blood eosinophil counts, as the diagnostic criteria explicitly require persistent peripheral blood eosinophilia ≥1.5 × 10⁹/L on two examinations at least one month apart. 1, 2

Diagnostic Criteria Are Absolute

The diagnosis of HES requires three essential, non-negotiable components 1, 2:

  • Peripheral blood eosinophilia ≥1.5 × 10⁹/L documented on two separate occasions at least one month apart
  • End-organ damage and/or dysfunction attributable to tissue eosinophilic infiltration (including thrombosis with or without thromboembolism) 1
  • Exclusion of other disorders or conditions as the major reason for organ damage 1

Without meeting the eosinophilia threshold in peripheral blood, the diagnosis of HES cannot be made, regardless of clinical presentation. 2, 3

Critical Distinction: Tissue vs. Blood Eosinophilia

While the guidelines acknowledge that tissue hypereosinophilia can occur, the standard diagnostic pathway still requires documentation of peripheral blood hypereosinophilia 2. The NCCN guidelines state that HES is defined as "blood HE with (plus) end-organ damage attributable to tissue HE" 1, emphasizing that blood eosinophilia is the primary criterion.

Thrombotic Complications in HES Context

When thrombotic complications do occur in confirmed HES, they are well-documented 1:

  • Thrombosis (with or without thromboembolism) is recognized as a specific form of HE-related organ damage 1
  • Thrombotic events occur in approximately 24% of HES patients and are significantly associated with increased mortality 4
  • Endomyocardial thrombosis and fibrosis are particularly common in primary (neoplastic) HES variants 3, 5
  • Patients with molecular aberrations on next-generation sequencing have 5.4-fold increased odds of thrombosis 4

What to Consider Instead

If a patient presents with thrombotic complications but has normal WBC and eosinophil counts, you must consider alternative diagnoses 1:

  • Clonal hematopoiesis of indeterminate potential - somatic mutations associated with hematologic malignancy can be detected in people with normal blood counts 1
  • Other hypercoagulable states unrelated to eosinophilia
  • Occult malignancy that has not yet manifested with eosinophilia
  • Secondary causes of thrombosis requiring standard thrombophilia workup

Common Pitfall to Avoid

Do not diagnose HES based solely on tissue eosinophilia or clinical suspicion without documented peripheral blood eosinophilia ≥1.5 × 10⁹/L. 2, 3 The peripheral blood eosinophil count is the gatekeeper for this diagnosis, and proceeding with HES-specific therapies (such as imatinib for PDGFRA-rearranged disease or corticosteroids) without meeting diagnostic criteria would be inappropriate and potentially harmful 1, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypereosinophilic Syndrome Diagnosis and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clinical Presentation and Diagnosis of Hypereosinophilic Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiovascular manifestations of hypereosinophilic syndromes.

Immunology and allergy clinics of North America, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.